BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
BUSINESS STRATEGY: Diversa delivers unparalleled enzyme performance for alternative fuels,
industrial, and health/nutrition processes. Diversa’s patented gene mining
and DirectEvolution technologies have yielded the world’s largest bank of
biodiverse enzymes. These enzymes enable manufacturers to make
products more efficiently and inexpensively while protecting the
environment. Diversa’s goal is to be the leadiing provider of industrial
enzymes and biologically active compounds for use in unique, economically
attractive applications.
The key elements of Diversa’s strategy are to:
Further enhance their technology leadership position
Continue strong focus on alternative fuel markets
Expand their existing DNA libraries through access to novel genetic material
and utilize our proprietary technologies to discover new genes and gene
pathways
Deploy their technologies across diverse markets in order to maximize their
return on investment
Pursue additional strategic alliances with market leaders to access funding
and industry-specific expertise
Independently develop and commercialize products in specific markets to
capture their full economic value
Discover, modify and commercialize protein-based enzyme catalysts for
chemical synthesis and industrial processes
Discover new lead drug compounds from bioactive pathways in
microorganisms and transgenic application of enzymes to plants for insect
and disease control
AGREEMENTS: Name Products Content of Agreement Date
BASF AG Diversa to discover and
optimize new enzymes,
BASF responsible for
product and process
development and
commercialization
alliance 2/06
Cargill Health and enzymes for the cost- discovery and 4/05
Food
effective production of a development
Technologies proprietary product agreement
Merck & Co. Inc. therapeutic antibodies development 1/05
using Diversa's MedEv agreement,
platform
expanded 6/05
RESEARCH & DEVELOPMENT: Alternative energy
Specialized industrial processes
Health and nutrition
PRODUCTS ON MARKET: Valley Ultra-Thin improves ethanol production
Luminase enzyme
Phyzyme XP enzyme (for pigs and chickens)
Quantum Phytase (for pigs and chickens)
Pyrolase 160 enzyme
ThermalAce DNA Polymerase
Bayovac® SRS (vaccine for farmed salmon, available in Chile)
PRODUCTS IN DEVELOPMENT: Name Status
Sordarins antifungal in preclinicals
Purifine (converts biomass to biofuel) in development
Amylase-T in regulatory review (U.S.)
Enzyme cocktail for cellulosic ethanol
production (unnamed)
in development
Phytase-T in development
Various antibodies, anti-SARs, anti-anthrax
and anti-plague antibodies
in development
Copyright ©2006 AHC Media ® 135